Trial by ordeal of unprecedented global pandemic
Innovations in precision medicine have the potential to transform healthcare and create tailor-made medical solutions for patients. Clinical Trials Insight talks to Mario Papillon, CEO of Cerba Research, about how his organisation is helping patients receive novel treatments faster by making clinical trials more efficient. This agility, combined with global access to industry-leading laboratories, has been key in the fight against Covid-19, and will continue to be an imperative in the new reality in which future clinical trials will have to exist.
Reach out to our experts and discover how we can help you advance your clinical trialContact Us